Starpharma Holdings Limited

DB:PQ6A Stock Report

Market Cap: €29.3m

Starpharma Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Cheryl Maley

Chief executive officer

AU$475.8k

Total compensation

CEO salary percentage51.3%
CEO tenureless than a year
CEO ownership0.03%
Management average tenureno data
Board average tenure3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Cheryl Maley's remuneration changed compared to Starpharma Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$476kAU$244k

-AU$8m

Compensation vs Market: Cheryl's total compensation ($USD306.25K) is below average for companies of similar size in the German market ($USD475.99K).

Compensation vs Earnings: Insufficient data to compare Cheryl's compensation with company performance.


CEO

Cheryl Maley (55 yo)

less than a year

Tenure

AU$475,764

Compensation

Mrs. Cheryl Maley, B.Sc, DipEd, MBA, GAICD, serves as Chief Executive Officer, Managing Director and Director of Starpharma Holdings Limited since January 8. 2024. She served as Non-Executive Director of C...


Board Members

NamePositionTenureCompensationOwnership
Cheryl Maley
CEO, MD & Directorless than a yearAU$475.76k0.030%
€ 8.8k
Robert Thomas
Non-Executive Chairman11yrsAU$136.95k0.73%
€ 214.0k
David McIntyre
Non-Executive Director4.8yrsAU$81.00k0.10%
€ 29.6k
Jeff Davies
Non-Executive Director2.7yrsAU$75.00k0.22%
€ 65.2k
Russell Basser
Non-Executive Director1.8yrsAU$77.04k0.065%
€ 19.0k
Lynda Cheng
Independent Non-Executive Director3.3yrsAU$88.54k0.041%
€ 12.0k

3.0yrs

Average Tenure

61yo

Average Age

Experienced Board: PQ6A's board of directors are considered experienced (3 years average tenure).